Delivery Order SPE2DR25D9127-SPE2DR26FCZY3
Award Date 4/21/26
Potential Completion Date 4/22/26
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 24, 2026, for JAKAFI 5 mg tablets (60-count units) with a ceiling value of $25,441.84. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables...
- The Defense Logistics Agency issued a $12,603.07 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 25, 2026, for JAKAFI 25 mg tablets (60-count unit). The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations...
- <p>The Defense Logistics Agency issued a $25,165.90 delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for JAKAFI 15 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order has a firm fixed-price structure with an ultimate completion date of March 11, 2026.</p>
- <p>The Defense Logistics Agency issued a $75,497.70 delivery order to DMS Pharmaceutical Group Inc. on April 21, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for JAKAFI 15 mg tablets (60-count units). Ultimate completion date is April 22, 2026.</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, Illinois. The order is priced on a firm fixed-price basis with no set-aside designation.</p>
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 25, 2026, for JAKAFI 15 mg tablets (60-count units) with a ceiling value of $12,582.95 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is issued under PPV-G GEN V, the Defense Logistics Agency's single-award indefinite delivery contract (awarded to DMS Pharmaceutical Group on...
- The Defense Logistics Agency issued a $12,720.92 delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for JAKAFI 5 mg tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The order is issued under PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide....
- <p>The Defense Logistics Agency issued a $72,615.58 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for JAKAFI 10 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group is a woman-owned small business. Place of performance is Park Ridge, Illinois. Ultimate completion date is March 3, 2026. The order is priced firm fixed price with no set-aside designation.</p>
- The Defense Logistics Agency issued a $25,326.56 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for JAKAFI 10 mg tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois. The order has a firm fixed-price structure with an ultimate completion date of March 3, 2026. The PPV-G GEN V is a Defense Logistics Agency...
- The Defense Logistics Agency issued a $50,883.68 delivery order to DMS Pharmaceutical Group Inc. on April 16, 2026, for JAKAFI 5 mg tablets (60 count) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical is a woman-owned small business holding the single-award indefinite delivery contract SPE2DX under PPV-G GEN V, which carries a $499.999 billion ceiling and runs through December 31, 2036. Place of performance is Park Ridge, Illinois. The order...
- The Defense Logistics Agency issued a $12,582.95 delivery order to DMS Pharmaceutical Group Inc. on March 16, 2026, for JAKAFI 15 mg tablets (60-count) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's comprehensive pharmaceutical supply contract supporting Department of Defense healthcare operations globally with branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables....